OOIR: Observatory of International Research

Papers

(The median citation count of American Journal of Respiratory and Critical Care Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome	1005
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline	745
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study	627
COVID-19 with Different Severities: A Multicenter Study of Clinical Features	590
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline	489
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline	485
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2	465
Characterization of the Inflammatory Response to Severe COVID-19 Illness	436
Why COVID-19 Silent Hypoxemia Is Baffling to Physicians	415
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease	393
Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19	371
COVID-19–related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids	323
Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study	318
Endothelial Responses in Sepsis	283
A Single-Cell Atlas of the Human Healthy Airways	267
COVID-19–associated Pulmonary Aspergillosis	266
Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2	254
Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2	249
Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis	231
Tissue-Specific Immunopathology in Fatal COVID-19	226
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations	225
Lung Recruitability in COVID-19–associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study	217
Basing Respiratory Management of COVID-19 on Physiological Principles	202
Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective	198
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis	197

Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients	191
Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline	191
Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis	190
Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium	188
Symptoms of Anxiety, Depression, and Peritraumatic Dissociation in Critical Care Clinicians Managing Patients with COVID-19. A Cross-Sectional Study	182
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes	179
High-Flow Nasal Cannula in Critically III Patients with Severe COVID-19	173
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study	159
SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients	158
Lung- and Diaphragm-Protective Ventilation	151
Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology	149
Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome	149
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele	144
Early Inspiratory Effort Assessment by Esophageal Manometry Predicts Noninvasive Ventilation Outcome in De Novo Respiratory Failure. A Pilot Study	143
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial	140
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease	140
The Structural and Social Determinants of the Racial/Ethnic Disparities in the U.S. COVID-19 Pandemic. What’s Our Role?	135
Ventilatory Variables and Mechanical Power in Patients with Acute Respiratory Distress Syndrome	135
Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease	132
Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications	131
Air Pollution, Genetic Factors, and the Risk of Lung Cancer: A Prospective Study in the UK Biobank	128
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection	126
Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline	125
Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU	124
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study	124
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline	123
Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement	120
Static and Dynamic Contributors to Ventilator-induced Lung Injury in Clinical Practice. Pressure, Energy, and Power	119
Latent Class Analysis Reveals COVID-19–related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids	116
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal	114
Respiratory Mechanics of COVID-19– versus Non–COVID-19–associated Acute Respiratory Distress Syndrome	113
Aerosol Generation from the Respiratory Tract with Various Modes of Oxygen Delivery	110
From GOLD 0 to Pre-COPD	110
Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical	109
Effect of Lowering Vt on Mortality in Acute Respiratory Distress Syndrome Varies with Respiratory System Elastance	108
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary	107
Ineffectual Type 2–to–Type 1 Alveolar Epithelial Cell Differentiation in Idiopathic Pulmonary Fibrosis: Persistence of the KRT8^hi Transitional State	105
Secretory Cells Dominate Airway CFTR Expression and Function in Human Airway Superficial Epithelia	104
Effect of Weight Loss on Upper Airway Anatomy and the Apnea–Hypopnea Index. The Importance of Tongue Fat	102
Sleep Apnea–Specific Hypoxic Burden, Symptom Subtypes, and Risk of Cardiovascular Events and All-Cause Mortality	101
Machine Learning Classifier Models Can Identify Acute Respiratory Distress Syndrome Phenotypes Using Readily Available Clinical Data	101
Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules	101
Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case–Control Study	101
Inflammatory Endotype–associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis	100
Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision	100
Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency	99
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis	99
Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs	99
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease	98
Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia	97

Mitigating Inequities and Saving Lives with ICU Triage during the COVID-19 Pandemic	94
Mechanical Ventilation for Acute Respiratory Distress Syndrome during Extracorporeal Life Support. Research and Practice	94
Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland	94
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension	89
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial	89
Injury to the Endothelial Glycocalyx in Critically Ill Patients with COVID-19	89
New Physical, Mental, and Cognitive Problems 1 Year after ICU Admission: A Prospective Multicenter Study	88
Sleep Apnea and COVID-19 Mortality and Hospitalization	88
The Early Change in Pa_CO₂after Extracorporeal Membrane Oxygenation Initiation Is Associated with Neurological Complications	88
The Sleep Apnea–Specific Pulse-Rate Response Predicts Cardiovascular Morbidity and Mortality	86
Characterization of Disease Phenotype in Very Preterm Infants with Severe Bronchopulmonary Dysplasia	86
High Prevalence of Pulmonary Sequelae at 3 Months after Hospital Discharge in Mechanically Ventilated Survivors of COVID-19	86
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial	84
The Epidemiological Importance of Subclinical Tuberculosis. A Critical Reappraisal	83
Lung Ultrasound to Monitor Extremely Preterm Infants and Predict Bronchopulmonary Dysplasia. A Multicenter Longitudinal Cohort Study	82
ACE2 Elevation in Severe COVID-19	82
Necroptosis Signaling Promotes Inflammation, Airway Remodeling, and Emphysema in Chronic Obstructive Pulmonary Disease	82
Respiratory Syncytial Virus Infection Promotes Necroptosis and HMGB1 Release by Airway Epithelial Cells	82
Airway Occlusion Pressure As an Estimate of Respiratory Drive and Inspiratory Effort during Assisted Ventilation	81
Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis	80
Changes to Visitation Policies and Communication Practices in Michigan ICUs during the COVID-19 Pandemic	78
Compliance Phenotypes in Early Acute Respiratory Distress Syndrome before the COVID-19 Pandemic	78
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled T	78
Natural History of Cognitive Impairment in Critical Illness Survivors. A Systematic Review	77
Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial	77
Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial	76
Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline	76
Characterization of GDF2 Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension	76
Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis	73
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles	72
Ventilator Sharing during an Acute Shortage Caused by the COVID-19 Pandemic	70
Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes	70
Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease	70
Using Bayesian Methods to Augment the Interpretation of Critical Care Trials. An Overview of Theory and Example Reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial	70
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward	70
Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials	69
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers	69
Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea	69
Asthma and Obstructive Sleep Apnea Overlap: What Has the Evidence Taught Us?	69
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances	68
Bronchoscopy in Patients with COVID-19 with Invasive Mechanical Ventilation: A Single-Center Experience	68
Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline	68
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial	68
Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease	67
Ventilatory Ratio in Hypercapnic Mechanically Ventilated Patients with COVID-19–associated Acute Respiratory Distress Syndrome	67
High Respiratory Drive and Excessive Respiratory Efforts Predict Relapse of Respiratory Failure in Critically Ill Patients with COVID-19	67
Prevalence, Characteristics, and Prognosis of Early Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study	66
Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial	66
Air Pollution as a Risk Factor for Incident Chronic Obstructive Pulmonary Disease and Asthma. A 15-Year Population-based Cohort Study	65
Respiratory and Cardiovascular Outcomes in Survivors of Extremely Preterm Birth at 19 Years	65
A Case of COVID-19 and Pneumocystis jirovecii Coinfection	65
Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study	64
Equitably Allocating Resources during Crises: Racial Differences in Mortality Prediction Models	63
Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures	63
Single-Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell	63
Pulmonary Vascular Dilatation Detected by Automated Transcranial Doppler in COVID-19 Pneumonia	63
Home Nitric Oxide Therapy for COVID-19	62
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis	62
Airway Mucus Hyperconcentration in Non–Cystic Fibrosis Bronchiectasis	62
Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial	62
Early Bacterial Identification among Intubated Patients with COVID-19 or Influenza Pneumonia: A European Multicenter Comparative Clinical Trial	62
Latent Tuberculosis: Two Centuries of Confusion	62
Airspace Macrophages and Monocytes Exist in Transcriptionally Distinct Subsets in Healthy Adults	61
Decreased Fatty Acid Oxidation and Altered Lactate Production during Exercise in Patients with Post-acute COVID-19 Syndrome	61
Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study	61
Detection of Invasive Pulmonary Aspergillosis in COVID-19 with Nondirected BAL	60
Reconsidering the Utility of Race-Specific Lung Function Prediction Equations	60
Chemokine Receptor 2–targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial	59
Effect of Positive End-Expiratory Pressure and Proning on Ventilation and Perfusion in COVID-19 Acute Respiratory Distress Syndrome	59
Endotypic Mechanisms of Successful Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea	59
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease	58
YTHDF1 Regulates Pulmonary Hypertension through Translational Control of MAGED1	58
Prone Positioning of Nonintubated Patients with COVID-19	58
Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease	57
Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data	57
Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists	57
Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon	56
Effects of Weight Loss on Obstructive Sleep Apnea Severity. Ten-Year Results of the Sleep AHEAD Study	56
TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis	56
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial	56

Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19	55
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia	54
Sustained Coinfections withStaphylococcus aureusandPseudomonas aeruginosain Cystic Fibrosis	54
Electrical Impedance Tomography for Positive End-Expiratory Pressure Titration in COVID-19–related Acute Respiratory Distress Syndrome	54
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review	54
Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis	54
Opioid Use Increases the Risk of Delirium in Critically Ill Adults Independently of Pain	53
Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19–related Acute Respiratory Distress Syndrome: Worth the Effort?	53
Episodic Aspiration with Oral Commensals Induces a MyD88-dependent, Pulmonary T-Helper Cell Type 17 Response that Mitigates Susceptibility to Streptococcus pneumoniae	53
Diagnosis and Management of COVID-19 Disease	53
Bronchial Thermoplasty Induced Airway Smooth Muscle Reduction and Clinical Response in Severe Asthma. The TASMA Randomized Trial	53
Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis	52
Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection	52
Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease	52
Extracorporeal Membrane Oxygenation for COVID-19–associated Severe Acute Respiratory Distress Syndrome in Chile: A Nationwide Incidence and Cohort Study	51
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement	51
Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality	51
Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement	50
Hospital-Free Days: A Pragmatic and Patient-centered Outcome for Trials among Critically and Seriously Ill Patients	50
Single-Session Bronchial Thermoplasty Guided by ¹²⁹Xe Magnetic Resonance Imaging. A Pilot Randomized Controlled Clinical Trial	50
Human Fetal Lungs Harbor a Microbiome Signature	50
The Effect of Sleep Apnea on Cardiovascular Events in Different Acute Coronary Syndrome Phenotypes	50
Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment	49
Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease	49
A Network of Sputum MicroRNAs Is Associated with Neutrophilic Airway Inflammation in Asthma	49
What Is Asthma?	49
Prone Position and Lung Ventilation and Perfusion Matching in Acute Respiratory Failure due to COVID-19	48
Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study	48
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomiz	48
Respiratory Tract Dysbiosis Is Associated with Worse Outcomes in Mechanically Ventilated Patients	48
Continuous Positive Airway Pressure Adherence for Prevention of Major Adverse Cerebrovascular and Cardiovascular Events in Obstructive Sleep Apnea	47
Hyperoxia Injury in the Developing Lung Is Mediated by Mesenchymal Expression of Wnt5A	47
The POOR Get POORer: A Hypothesis for the Pathogenesis of Ventilator-induced Lung Injury	47
High In-Hospital Mortality Rate in Patients with COVID-19 Receiving Extracorporeal Membrane Oxygenation in Germany: A Critical Analysis	47
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial	47
Urinary Leukotriene E₄and Prostaglandin D₂Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study	46
Sex Differences in Right Ventricular–Pulmonary Arterial Coupling in Pulmonary Arterial Hypertension	46
Interventional Bronchoscopy	46
Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial	46
Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19	46
Race, Lung Function, and Long-Term Mortality in the National Health and Nutrition Examination Survey III	45
Comparative Effectiveness of Protective Ventilation Strategies for Moderate and Severe Acute Respiratory Distress Syndrome. A Network Meta-Analysis	45
Importance of Early COPD in Young Adults for Development of Clinical COPD. Findings from the Copenhagen General Population Study	45
COVID-19 and Public Interest in Face Mask Use	45
Peri-intubation Cardiovascular Collapse in Patients Who Are Critically Ill: Insights from the INTUBE Study	45
Effect of Esophageal Pressure–guided Positive End-Expiratory Pressure on Survival from Acute Respiratory Distress Syndrome: A Risk-based and Mechanistic Reanalysis of the EPVent-2 Trial	45
Inhibition of Caspase-1 with Tetracycline Ameliorates Acute Lung Injury	45
Outcomes Six Months after Delivering 100% or 70% of Enteral Calorie Requirements during Critical Illness (TARGET). A Randomized Controlled Trial	45
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles	44
Radiology–Pathology Correlation Demonstrating Organizing Pneumonia in a Patient Who Recovered from COVID-19	44
COVID-19– versus non–COVID-19–related Acute Respiratory Distress Syndrome: Differences and Similarities	44
Prevalence and Population-Attributable Risk for Chronic Airflow Obstruction in a Large Multinational Study	44
Localization of Macrophages in the Human Lung via Design-based Stereology	43
Recurrent Severe Preschool Wheeze: From Prespecified Diagnostic Labels to Underlying Endotypes	43
Tracheal Intubation in the Critically Ill. Where We Came from and Where We Should Go	43
Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ	43
Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling	43
Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19	43
Gender Differences in Authorship of Critical Care Literature	43
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment	43
Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome	43
Associations of Sleep-disordered Breathing and Insomnia with Incident Hypertension and Diabetes. The Hispanic Community Health Study/Study of Latinos	43
Cigarette Smoking and COVID-19: A Complex Interaction	42
Temporal Trends in Critical Care Outcomes in U.S. Minority-Serving Hospitals	42
Exposure to Violence, Psychosocial Stress, and Asthma	42
Is Computed Tomography Airway Count Related to Asthma Severity and Airway Structure and Function?	42
PERSEVERE Biomarkers Predict Severe Acute Kidney Injury and Renal Recovery in Pediatric Septic Shock	41
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome	41
Long-Term Outcomes in ICU Patients with Delirium: A Population-based Cohort Study	41
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis	41
Positive End-Expiratory Pressure, Pleural Pressure, and Regional Compliance during Pronation. An Experimental Study	41
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study	41
Muscle Protein Synthesis after Protein Administration in Critical Illness	41
Trajectory of Preserved Ratio Impaired Spirometry: Natural History and Long-Term Prognosis	41
Impulse Dispersion of Aerosols during Singing and Speaking: A Potential COVID-19 Transmission Pathway	40
Risk-stratified Management to Remove Low-Risk Penicillin Allergy Labels in the ICU	40
Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Analysis of Case–Control Studies	40
Chronic Effects of High Fine Particulate Matter Exposure on Lung Cancer in China	40
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review	40
Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial	40
E-Cigarette or Vaping Product Use–associated Lung Injury: Developing a Research Agenda. An NIH Workshop Report	40
Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis	40
Effects of Inhaled Corticosteroid/Long-Acting β₂-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial	40
Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non–COVID-19 Critical Illness	40
Positive Airway Pressure Adherence, Mortality, and Cardiovascular Events in Patients with Sleep Apnea	40
Airway Sensory Nerve Density Is Increased in Chronic Cough	40
Identifying Clinical Research Priorities in Adult Pulmonary and Critical Care. NHLBI Working Group Report	39
Circulating MicroRNAs and Treatment Response in Childhood Asthma	39
rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia	39
Biological Subphenotypes of Acute Respiratory Distress Syndrome Show Prognostic Enrichment in Mechanically Ventilated Patients without Acute Respiratory Distress Syndrome	39
Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma	39
Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial	39
Aspergillus Infections and Progression of Structural Lung Disease in Children with Cystic Fibrosis	39
Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure due to COVID-19: A Matched Control Study	39
Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study	39